CancerAid is an early-stage healthtech startup that has developed the number 1 cancer app in the US, UK and Australia and is already helping 20,000 patients globally. The app provides patients and caregivers with a digital companion through each stage of their journey; from the moment of diagnosis, through to treatments and into survivorship. The app is free to users, and eMR integration is licensed as a subscription to US Health systems like Cedars-Sinai to help improve symptom management. Customers who utilize this symptom journal integration are able to reduce ER visits and 30 day readmissions, improve patient satisfaction and quality of life, but most important randomized evidence has shown that cancer patients can live longer! CancerAid is revolutionising the way cancer care is delivered to cancer patients, caregivers and clinicians. Apple have showcased CancerAid as their flagship health app, and the Founders secured one of the largest deals in Shark Tank history. Along with this, they were recently awarded as the ‘Best Global Startup’ by Sir Richard Branson, and the ‘Best Global Startup Creating Social Impact’ by Steve Wozniak, so CancerAid’s stock is truly on the rise. Cancer patients expect, need and deserve timely access to the best possible care, and CancerAid aims to achieve it. The team are determined, personable and passionate working on the initiative to improve cancer care on a global scale.
You're browsing HLTH 2018's website. Visit hlth.com to explore this year's edition!